Abstract Objective To observe the effects of bacterial lysates (OM-85BV) and all trans-retinoic acid (ATRA) on airway inflammation in asthmatic mice, and to investigate the immunoregulatory mechanism of OM-85BV and ATRA for airway inflammation in asthmatic mice. Methods Forty female BALB/c mice were randomly divided into five groups: normal control, model, OM-85BV, ATRA, and OM-85BV+ATRA. A bronchial asthma model was established by intraperitoneal injection of ovalbumin (OVA) for sensitization and aerosol challenge in all mice except those in the normal control group. On days 25-34, before aerosol challenge, the model, OM-85BV, ATRA, and OM-85BV+ATRA groups were given normal saline, OM-85BV, ATRA, and OM-85BV+ATRA respectively by gavage. Normal saline was used instead for sensitization, challenge, and pretreatment before challenge in the normal control group. These mice were anesthetized and dissected at 24-48 hours after the final challenge. Bronchoalveolar lavage fluid (BALF) was collected from the right lung to measure the levels of interleukin-10 (IL-10) and interleukin-17 (IL-17) by ELISA. The left lung was collected to observe histopathological changes by hematoxylin-eosin staining. The relative expression of ROR-γT mRNA was measured by quantitative real-time PCR. Results Compared with the normal control group, the model group showed contraction of the bronchial cavity, increased bronchial secretions, and a large number of infiltrating inflammatory cells around the bronchi and alveolar walls, as well as a significantly reduced level of IL-10 (P < 0.05) and significantly increased levels of IL-17 and ROR-γT mRNA (P < 0.05). Compared with the model group, the OM-85BV, ATRA, and OM-85BV+ATRA groups showed a significant reduction in infiltrating inflammatory cells around the bronchi and alveolar walls; the OM-85BV group showed a significant increase in the level of IL-10 in BALF (P < 0.05) and significant reductions in the levels of IL-17 and ROR-γT mRNA (P < 0.05); the ATRA group showed significant reductions in the levels of IL-17 and ROR-γT mRNA (P < 0.05). Compared with the OM-85BV group, the OM-85BV+ATRA group had significantly increased relative expression of ROR-γT mRNA (P < 0.05). Compared with the ATRA group, the OM-85BV+ATRA group had significantly increased levels of IL-10 and IL-17 in BALF (P < 0.05). Conclusions Both OM-85BV and ATRA can reduce respiratory inflammation in asthmatic mice. However, a combination of the two drugs does not have a better effect than them used alone.
LEI Yuan,KUANG Shou-Jin,LIAO Cai-Shi. Effects of bacterial lysates and all trans-retinoic acid on airway inflammation in asthmatic mice[J]. CJCP, 2018, 20(6): 514-518.
LEI Yuan,KUANG Shou-Jin,LIAO Cai-Shi. Effects of bacterial lysates and all trans-retinoic acid on airway inflammation in asthmatic mice[J]. CJCP, 2018, 20(6): 514-518.
Horak F, Doberer D, Eber E, et al. Diagnosis and management of asthma-Statement on the 2015 GINA Guidelines[J]. Wien Klin Wochenschr, 2016, 128(15-16):541-554.
[2]
Umlawska W, Gaszczyk G, Sands D. Physical development in children and adolescents with bronchial asthma[J]. Respir Physiol Neurobiol, 2013, 187(1):108-113.
[3]
Strickland DH, Judd S, Thomas JA, et al. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control[J]. Mucosal Immunol, 2011, 4(1):43-52.
Sakamoto H, Koya T, Tsukioka K, et al. The effects of all-trans retinoic acid on the induction of oral tolerance in a murine model of bronchial asthma[J]. Int Arch Allergy Immunol, 2015, 167(3):167-176.
[8]
Bessler WG, Vor dem Esche U, Masihi N. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection[J]. Int Immunopharmacol, 2010, 10(9):1086-1090.
[9]
Ray A, Khare A, Krishnamoorthy N, et al. Regulatory T cells in many flavors control asthma[J]. Mucosal Immunol, 2010, 3(3):216-229.
[10]
Shi YH, Shi GC, Wan HY, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma[J]. Chin Med J (Engl), 2011, 124(13):1951-1956.
[11]
Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORγt[J]. Nat Immunol, 2008, 9(6):641-649.
[12]
Ivanov Ⅱ, Mckenzie BS, Zhou L, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells[J]. Cell, 2006, 126(6):1121-1133.
Chen F, Marquez H, Kim YK, et al. Prenatal retinoid deficiency leads to airway hyperresponsiveness in adult mice[J]. J Clin Invest, 2014, 124(2):801-811.
[15]
Niu C, Liu N, Liu J, et al. Vitamin A maintains the airway epithelium in a murine model of asthma by suppressing glucocorticoid-induced leucine zipper[J]. Clin Exp Allergy, 2016, 46(6):848-860.
Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression[J]. J Immunol, 2008, 181(4):2277-2284.
[18]
Fu R, Li J, Zhong H, et al. Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3β-related T regulatory cell insufficiency[J]. PLoS One, 2014, 9(3):e92912.
[19]
Han RF, Li HY, Wang JW, et al. Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom[J]. Eur Rev Med Pharmacol Sci, 2016, 20(10):2151-2155.
[20]
Fujii U, Miyahara N, Taniguchi A, et al. Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma[J]. Respir Res, 2017, 18(1):23.
[21]
Luo ZX, Liu EM, Luo J, et al. Vitamin A deficiency and wheezing[J]. World J Pediatr, 2010, 6(1):81-84.
